LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
151,800
+4,900 (3.34%)
Sep 3, 2025, 2:40 PM KST
3.34%
Market Cap5.33T
Revenue (ttm)148.28B
Net Income (ttm)1.75B
Shares Out36.25M
EPS (ttm)47.50
PE Ratio3,040.26
Forward PE106.27
Dividendn/a
Ex-Dividend Daten/a
Volume283,735
Average Volume354,392
Open147,200
Previous Close146,900
Day's Range144,100 - 152,400
52-Week Range79,400 - 158,900
Beta0.83
RSI53.80
Earnings DateAug 14, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.